We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

USCB:NASDAQUSCB Financial Holdings, Inc. Analysis

Data as of 2026-09-01 - not real-time

$22.26

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

USCB Financial Holdings, Inc. trades at $22.26, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. Over a rolling month the price has gained 9.0%. With RSI at 54.4 the momentum picture is neutral, alongside a bearish MACD signal. Price has been bracketed by support at $21.77 and resistance at $23.89.
On valuation the read is undervalued — earnings multiple of 14.3 versus a 16.7 sector average, below the peer group. Sell-side targets cluster 9.4% above the current quote. Revenue is growing at 14.1% on a 30.4% profit margin. The 2.14% dividend yield looks covered by current payout levels.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 26.8%, a beta of 0.45 and a maximum drawdown of 14.2%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
All three time horizons resolve to buy, carrying 6/10 conviction.

Top Market Events

Although the revenue and EPS for USCB Financial USCB give a sense of how its business performed in the quarter ended...USCB Financial USCB delivered earnings and revenue surprises of 0.MIAMI, July 23, 2026 GLOBE NEWSWIRE -- USCB Financial Holdings, Inc.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 19.50
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 14.3 versus sector average of 16.7
  • Trading above the 200-day average of 19.50

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 14.3 versus sector average of 16.7
  • Analyst targets imply +9.4% versus the current price
  • Profit margin of 30.4% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth14.10%
Profit Margin30.41%
P/E Ratio14.3
ROE12.36%
ROA1.00%
P/B Ratio1.8
Op. Cash Flow$50.1M
Industry P/E16.7

Technical Analysis

TrendBullish
RSI54.4
Support$21.77
Resistance$23.89
MA 20$22.39
MA 50$21.43
MA 200$19.50
MACDBearish
VolumeIncreasing
Fear & Greed Index92.25

Valuation

Fair Value$33.79
Target Price$24.35
Upside/Downside9.39%
GradeUndervalued
TypeBlend
Dividend Yield2.14%

Risk Assessment

Beta0.45
Volatility26.75%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.